BioClinica's VP Commercial Operations was just granted 17,500 options

Raaj Trivedi, BioClinica's VP Commercial Operations, just received 17,500 options from the company. The strike price of the options received was $1.34, and these expire on February 28, 2026. Trivedi now owns at least 17,500 options on the company.

Some additional info was provided as follows:

25% of the shares subject to the option shall vest on the first annual anniversary of the Vesting Commencement Date (2/29/16) with the balance vesting in equal monthly installments thereafter until fully vested on February 29, 2020.

The above information was disclosed in a filing to the SEC. To see the filing, click here.

To re ceive a free e-mail notification whenever BioClinica makes a similar move, sign up!

Other recent filings from the company include the following:

Registration statement under Securities Act of 1933 - Aug. 18, 2017
Bin Li just provided an update on activist position in Biocept - Aug. 17, 2017
Major owner of Biocept just declared owning 3,147,667 shares of Biocept - Aug. 17, 2017
Notice of Exempt Offering of Securities, item 06b - Aug. 14, 2017
Biocept Just Filed Its Quarterly Report: 10. Net Loss per Co... - Aug. 14, 2017

Auto Refresh

Feedback